Feature-specific salience maps in human cortex

Autor: Daniel D. Thayer, Thomas C. Sprague

Priority maps are representations of visual space that determine the relative importance of scene locations. Computational theories suggest that priority maps identify salient locations based on individual feature dimensions (e.g., color, motion), wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d3f6f1bfec3e82bdc45742ac98ebf83
https://doi.org/10.1101/2023.03.29.534828

Learned feature regularities enable suppression of spatially overlapping stimuli

Autor: Daniel D, Thayer, Maggie, Miller, Barry, Giesbrecht, Thomas C, Sprague

Publikováno v: Attention, perceptionpsychophysicsReferences.

Contemporary theories of attentional control state that information can be prioritized based on selection history. Even though theories agree that selection history can impact representations of spatial location, which in turn helps guide attention,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c22eef1ccb963c2e8a20e2fdbe7792ed
https://pubmed.ncbi.nlm.nih.gov/36417129

The Architecture of Interaction between Visual Working Memory and Attention: Features from Multiple Remembered Objects Produce Parallel, Coactive Guidance

Autor: Daniel D. Thayer, J. Toby Mordkoff, Andrew Hollingworth, Brett Bahle

Publikováno v: Journal of Vision. 19:213c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d6e172c496ec5259877de51b4855334
https://doi.org/10.1167/19.10.213c

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

Autor: Hurley E; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Geisler BP; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lupattelli A; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Poblador-Plou B; EpiChron Research Group, Aragon Health Sciences Institute, Miguel Servet University Hospital, Saragossa, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion, Research Network on Health Services in Chronic Diseases, Institute of Health Carlos III, Madrid, Spain., Lassalle R; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Jové J; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Bernard MA; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sakr D; Bordeaux PharmacoEpi, Plateforme de recherche en Pharmaco-épidémiologie, Bordeaux, France., Sanfélix-Gimeno G; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sánchez-Saez F; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Rodríguez-Bernal CL; Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain., Sabaté M; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Ballarín E; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Aguilera C; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain., Jordan S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Thayer D; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Farr I; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Ahmed S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales, UK., Bartolini C; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Limoncella G; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Paoletti O; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Gini R; Agenzia Regionale di Sanità della Toscana, Florence, Italy., Maglanoc LA; IT Department, Data Management, University of Oslo, Oslo, Norway., Dudukina E; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Alsina E; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Vaz TA; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Riera-Arnau J; Department of Clinical Pharmacology, Vall d`Hebron Hospital Universitari, Vall Hebron Institut de Recerca, Barcelona, Spain.; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Sturkenboom MCJM; Department of Data Science and Biostatistics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Nordeng HME; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.; Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway. h.m.e.nordeng@farmasi.uio.no.

Publikováno v: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 May; Vol. 80 (5), pp. 707-716. Date of Electronic Publication: 2024 Feb 12.

From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding.

Autor: Thurin NH; Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, Bordeaux, France., Pajouheshnia R; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Roberto G; Agenzia regionale di sanità della Toscana, Florence, Italy., Dodd C; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Hyeraci G; Agenzia regionale di sanità della Toscana, Florence, Italy., Bartolini C; Agenzia regionale di sanità della Toscana, Florence, Italy., Paoletti O; Agenzia regionale di sanità della Toscana, Florence, Italy., Nordeng H; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Wallach-Kildemoes H; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark., Dudukina E; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark., MacDonald T; MEMO Research, School of Medicine, University of Dundee, Dundee, UK., De Paoli G; MEMO Research, School of Medicine, University of Dundee, Dundee, UK., Loane M; Institute of Nursing and Health Research, Ulster University, Newtownabbey, UK., Damase-Michel C; INSERM, CERPOP: SPHERE, CIC 1436, Université de Toulouse, Toulouse, France., Beau AB; INSERM, CERPOP: SPHERE, CIC 1436, Université de Toulouse, Toulouse, France., Droz-Perroteau C; Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, Bordeaux, France., Lassalle R; Bordeaux PharmacoEpi, INSERM CIC-P1401, Univ. Bordeaux, Bordeaux, France., Bergman J; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Swart K; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Schink T; Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany., Cavero-Carbonell C; Fundació per al Foment de la Investigació Sanitaria i Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain., Barrachina-Bonet L; Fundació per al Foment de la Investigació Sanitaria i Biomédica de la Comunitat Valenciana (FISABIO), Valencia, Spain., Gomez-Lumbreras A; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Universitat Autònoma de Barcelona, Bellaterra, Spain., Giner-Soriano M; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Universitat Autònoma de Barcelona, Bellaterra, Spain., Aragón M; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Universitat Autònoma de Barcelona, Bellaterra, Spain., Neville AJ; IMER Registry (Emila Romagna Registry of Birth Defects), Center of Epidemiology for Clinical Research, University of Ferrara, Ferrara, Italy., Puccini A; Drug Policy Service, Emilia Romagna Region Health Authority, Bologna, Italy., Pierini A; Epidemiology of Rare Diseases and Congenital Anomalies Unit, National Research Council-Institute of Clinical Physiology (CNR-IFC), Pisa, Italy., Ientile V; Department of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Messina, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Rissmann A; Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty, Otto-von-Guericke-University, Magdeburg, Germany., Leinonen MK; Finnish Institute for Health and Welfare, Helsinki, Finland., Martikainen V; Finnish Institute for Health and Welfare, Helsinki, Finland., Jordan S; Faculty of Health and Life Science, Swansea University, Swansea, UK., Thayer D; Faculty of Health and Life Science, Swansea University, Swansea, UK., Scanlon I; Faculty of Health and Life Science, Swansea University, Swansea, UK., Georgiou ME; Glaxosmithkline, Stevenage, UK., Cunnington M; Glaxosmithkline, Stevenage, UK., Swertz M; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Sturkenboom M; Department Datascience and Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands., Gini R; Agenzia regionale di sanità della Toscana, Florence, Italy.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Jan; Vol. 111 (1), pp. 321-331. Date of Electronic Publication: 2021 Nov 26.